GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioqual Inc (OTCPK:BIOQ) » Definitions » Asset Turnover

Bioqual (Bioqual) Asset Turnover : 1.46 (As of May. 2018)


View and export this data going back to . Start your Free Trial

What is Bioqual Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Bioqual's Revenue for the six months ended in May. 2018 was $35.89 Mil. Bioqual's Total Assets for the quarter that ended in May. 2018 was $24.53 Mil. Therefore, Bioqual's Asset Turnover for the quarter that ended in May. 2018 was 1.46.

Asset Turnover is linked to ROE % through Du Pont Formula. Bioqual's annualized ROE % for the quarter that ended in May. 2018 was 35.76%. It is also linked to ROA % through Du Pont Formula. Bioqual's annualized ROA % for the quarter that ended in May. 2018 was 29.85%.


Bioqual Asset Turnover Historical Data

The historical data trend for Bioqual's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioqual Asset Turnover Chart

Bioqual Annual Data
Trend May01 May03 May04 May05 May06 May07 May10 May11 May17 May18
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.32 2.13 1.83 2.03 1.46

Bioqual Semi-Annual Data
May96 May97 May98 May99 May00 May01 May03 May04 May05 May06 May07 May10 May11 May17 May18
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.32 2.13 1.83 2.03 1.46

Competitive Comparison of Bioqual's Asset Turnover

For the Diagnostics & Research subindustry, Bioqual's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioqual's Asset Turnover Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bioqual's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Bioqual's Asset Turnover falls into.



Bioqual Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Bioqual's Asset Turnover for the fiscal year that ended in May. 2018 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: May. 2018 )/( (Total Assets (A: May. 2017 )+Total Assets (A: May. 2018 ))/ count )
=35.885/( (22.76+26.305)/ 2 )
=35.885/24.5325
=1.46

Bioqual's Asset Turnover for the quarter that ended in May. 2018 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: May. 2018 )/( (Total Assets (Q: May. 2017 )+Total Assets (Q: May. 2018 ))/ count )
=35.885/( (22.76+26.305)/ 2 )
=35.885/24.5325
=1.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Bioqual  (OTCPK:BIOQ) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Bioqual's annulized ROE % for the quarter that ended in May. 2018 is

ROE %**(Q: May. 2018 )
=Net Income/Total Stockholders Equity
=7.324/20.4825
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(7.324 / 71.77)*(71.77 / 24.5325)*(24.5325/ 20.4825)
=Net Margin %*Asset Turnover*Equity Multiplier
=10.2 %*2.9255*1.1977
=ROA %*Equity Multiplier
=29.85 %*1.1977
=35.76 %

Note: The Net Income data used here is two times the semi-annual (May. 2018) net income data. The Revenue data used here is two times the semi-annual (May. 2018) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Bioqual's annulized ROA % for the quarter that ended in May. 2018 is

ROA %(Q: May. 2018 )
=Net Income/Total Assets
=7.324/24.5325
=(Net Income / Revenue)*(Revenue / Total Assets)
=(7.324 / 71.77)*(71.77 / 24.5325)
=Net Margin %*Asset Turnover
=10.2 %*2.9255
=29.85 %

Note: The Net Income data used here is two times the semi-annual (May. 2018) net income data. The Revenue data used here is two times the semi-annual (May. 2018) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Bioqual Asset Turnover Related Terms

Thank you for viewing the detailed overview of Bioqual's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioqual (Bioqual) Business Description

Traded in Other Exchanges
N/A
Address
9600 Medical Center Drive, Suite 101, Rockville, MD, USA, 20850
Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.
Executives
Williams Frank E Jr other: Communication, See Remarks 2789-B HARTLAND ROAD, FALLS CHURCH VA 22043

Bioqual (Bioqual) Headlines

No Headlines